Is persistent mild hypercalcemia with an inappropriately normal or slightly elevated parathyroid hormone level still consistent with primary hyperparathyroidism?

Yes, this presentation is entirely consistent with primary hyperparathyroidism (PHPT)

Your patient's laboratory findings—persistent mild hypercalcemia (10.9 and 10.4 mg/dL) with a PTH that rose from 10 to 31 pg/mL—represent a classic "non-typical" form of PHPT where the PTH is inappropriately normal or only mildly elevated relative to the calcium level. This is a well-recognized presentation that should not delay diagnosis 1.

Understanding the Biochemical Pattern

The key diagnostic principle is that any detectable PTH in the setting of hypercalcemia is inappropriate. In a normally functioning parathyroid system, hypercalcemia should completely suppress PTH secretion to undetectable or very low levels 1. Your patient's PTH of 31 pg/mL (and even the initial 10 pg/mL) in the context of elevated calcium represents autonomous PTH secretion.

The First Blood Draw Consideration

The initial PTH of 10 during a "difficult blood draw" is particularly important to interpret correctly:

• Stress, hemolysis, or prolonged tourniquet time during difficult venipuncture can artificially affect results
• The repeat measurement showing PTH 31 with persistent hypercalcemia (10.4) is more reliable
• Both values, however, demonstrate the hallmark of PHPT: failure to suppress PTH appropriately in response to hypercalcemia 1

Diagnostic Framework for Non-Typical PHPT

According to the 2025 French consensus guidelines, non-typical PHPT includes 1:

1. Hypercalcemia with PTH in the "normal" laboratory range but physiologically inadequate (your patient's presentation)
2. Normocalcemic hyperparathyroidism with elevated PTH

Essential Next Steps

Before confirming PHPT diagnosis, you must exclude secondary causes that could mask the diagnosis 1:

Mandatory investigations:

• 25(OH) vitamin D level: Vitamin D deficiency can cause secondary hyperparathyroidism that may coexist with or mask PHPT. Correct to normal levels and reassess after 6+ months if initially deficient 1
• Fractional excretion of calcium (FeCa): Calculate using the formula: (urinary calcium × plasma creatinine)/(urinary creatinine × plasma calcium) × 100
  • FeCa >2% strongly supports PHPT 1
  • FeCa ≤2% suggests familial hypocalciuric hypercalcemia (FHH), which mimics PHPT but requires no treatment 2
• 24-hour urinary calcium: Typically elevated in PHPT (>300 mg/24h in men, >250 mg/24h in women) 1
• Ionized calcium: More precise than total calcium, especially useful in borderline cases 1

Screen for confounding factors:

• Adequate dietary calcium intake (use validated questionnaire)
• Renal function (eGFR)
• Medications: thiazide diuretics, lithium, excessive calcium/vitamin D supplementation
• Malabsorption conditions

Common Diagnostic Pitfall

The most critical error is dismissing PHPT because the PTH is "normal" by laboratory reference range. Research demonstrates that patients with hypercalcemia and PTH ≤50 pg/mL have proven PHPT with 96.7% surgical cure rates and similar clinical presentations to those with higher PTH levels 3. These patients often have multiglandular disease (58.9% vs 31.9% in higher PTH groups) 3.

Advanced Diagnostic Testing (If Needed)

If the diagnosis remains uncertain after correcting vitamin D and excluding secondary causes 1:

Oral calcium loading test:

• Administer 1 gram elemental calcium orally after fasting
• Measure calcium and PTH at baseline and 2 hours post-load
• In PHPT: PTH fails to suppress despite rising calcium (demonstrates autonomous secretion)
• In secondary hyperparathyroidism: PTH appropriately suppresses
• Requires experienced team for proper interpretation

Clinical Algorithm

1. Confirm persistent hypercalcemia (you have: 10.9 and 10.4 mg/dL) ✓
2. Document inappropriately non-suppressed PTH (you have: 10 and 31 pg/mL) ✓
3. Calculate FeCa → If >2%, strongly supports PHPT
4. Check 25(OH) vitamin D → If deficient, correct and recheck in 6+ months
5. Measure ionized calcium → Confirms true hypercalcemia
6. Assess for target organ damage: bone density scan, renal imaging for stones, assess for symptoms
7. If diagnosis confirmed, evaluate for surgical candidacy per established criteria

The Bottom Line

Your patient's biochemical pattern is not atypical or unusual—it represents a well-described presentation of PHPT that accounts for a significant proportion of cases 1, 3. The rise in PTH from 10 to 31 between measurements actually strengthens the diagnosis by demonstrating persistent autonomous secretion. Do not be falsely reassured by a "normal range" PTH value in the setting of hypercalcemia; this is the definition of inappropriate PTH secretion and warrants full PHPT workup 1.